Regulation

Regulation  105 CMR 270.00: Blood screening of newborns for treatable diseases and disorders

Date: 10/21/2016
Organization: Department of Public Health
Regulatory Authority: MGL c. 111, §§ 3, 4E, 5, 6, 24A, 110A
Official Version: Purchase the official print version

105 CMR 270.000: (A) lists those diseases and disorders with treatments that are known to be more effective if the condition is identified in the newborn/infant period and for which there is a reliable and effective blood screening test and diagnostic protocol; (B) ensures that every newborn is screened for markers of these diseases and disorders; and (C) makes available Optional Newborn Blood Screening for another set of diseases and disorders with treatments that are thought to be effective if the condition is identified in the newborn/infant period and for which testing shall be offered under an optional protocol to collect critical population-based data on prevalence of these diseases and disorders in the Massachusetts population, their natural history, and the efficacy of screening, diagnostic, and treatment protocols.

Download a PDF copy of the regulation below.

Contact for 105 CMR 270.00: Blood screening of newborns for treatable diseases and disorders

Trial Court Law Libraries

Table of Contents

Downloads for 105 CMR 270.00: Blood screening of newborns for treatable diseases and disorders

Contact for 105 CMR 270.00: Blood screening of newborns for treatable diseases and disorders

Help Us Improve Mass.gov with your feedback

Feedback